BeNeLuxA Makes First Positive Reimbursement Decision On Biogen’s Spinraza

In a BeNeLuxA first, Belgium and the Netherlands have reached an agreement with Biogen to reimburse rare disease treatment Spinraza after joint health technology assessment and pricing negotiations.